Consolidated Statements of Operations Statement (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
REVENUE:
Services	$ 162,974	$ 188,735
Product sales	50,669	74,168
Total revenue	213,643	262,903
OPERATING EXPENSES:
Cost of services, exclusive of depreciation expense shown below	102,795	110,571
Cost of product sales, exclusive of depreciation expense shown below	41,479	51,098
General and administrative expense, exclusive of depreciation expense shown below	12,674	10,519
Depreciation	6,345	6,342
Amortization	221	291
Other (income) expense, net	322	1,255
Severance and other charges	7,090	0
OPERATING INCOME	42,717	82,827
Interest expense	2,403	2,363
Income before income tax expense	40,314	80,464
Income tax expense	9,272	19,311
Net income	31,042	61,153
Net income (loss) attributable to non-controlling interest	(357)	89
Net income attributable to Core Laboratories N.V.	$ 31,399	$ 61,064
EARNINGS PER SHARE INFORMATION:
Basic earnings per share attributable to Core Laboratories N.V. (in dollars per share)	$ 0.72	$ 1.36
Diluted earnings per share attributable to Core Laboratories N.V. (in dollars per share)	$ 0.72	$ 1.35
Cash dividends per share (in dollars per share)	$ 0.55	$ 0.50
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic	43,340	44,908
Diluted	43,466	45,182